Careaga RG, Cardoza PHA

Language: Spanish
References: 12
Page: 77-81
PDF size: 137.96 Kb.

ABSTRACT

Background: The increase in the number of percutaneous coronary angioplasty and the higher risk of surgery when the angioplasty is complicated, we present the frequency and results of this procedure. Material and methods: From September 1, 1998 to august 31, 1999, 411 percutaneous coronary angioplasty was made. Urgent cardiac surgery was indicated in eight patients (6 male and 2 female), due to complications of the procedure. The mean age was 59.3 years, range of 35 to 72 years old. Results: In seven patients the internal mammary artery was employed for surgical revascularization and in six cases the intraaortic balloon pumping was used. The time between accident and surgery was 4.3 hours ranging 1 to 16 hours. It was 3 perioperative myocardial infarctions, one patient was reopened for excessive bleeding and this case developed a mediastinitis. One patient presented severe brain damage and 2 patients died due to refractory myocardial failure. The mean of in hospital length of stay was 32.5 days ranging 7 to 63 days. Conclusion: lt was concluded that despite a lower incidence for urgent cardiac surgery for complicating coronary angioplasty, the morbidity, mortality and length of stay increases. On the other side surgical procedures offers a complete revascularization.

REFERENCES

1. Ryan TJ, Bauman WB, Kennedy JW, Kereiakes DJ, King SB III, McCallister 13D y cols. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association task force on assessment of diagnostic and therapeutic cardiovascular procedures (Committee on Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 1993; 22: 2033-54.

2. Saatvedt K, Norstrand K, Vatne K, Geiran O, Lindberg H, Froysaker T. Surgical intervention following failed percutaneous coronary angioplasty. Scand J Thorac Cardiovasc Surg 1993; 27: 9-13.

3. Killen DA, Hamaker WR, Reed WA. Coronary artery bypass following percutaneous transluminal coronary angioplasty. Ann Thorac Surg 1985; 40: 133-8.

4. Lazar HL, Jacobs AK, Aldea GS, Shapira OM, Lancaster D, Shemin RJ. Factors influencing mortality after emergency coronary artery bypass grafting for failed percutaneous transluminal coronary angioplasty. Ann Thorac Surg 1997; 64: 1747-52.

5. Ladowski JS, Dillon TA, Deschner WP, DeRiso AJ, Peterson AC, Schatzlein MH. Durability of emergency coronary artery bypass for complications of failed angioplasty. Cardiovasc Surg 1996; 4: 23-7.

6. Gray HH, Swanton RH, Schofeld PM, Murray RG, Brooksby I, Venn GE y cols. Coronary angioplasty: guidelines for good practice and training. Heart 2000; 83: 224-35.

7. Musiani A, Pagani L, Cao M, Bemardi M, Mazzarotto P, Cernigliaro C, De Gasperis C. Emergency coronary surgery after failed angioplasty: 11 years of experience (1987-1997). G Ital Cardiol 1998; 28: 774-80.

8. Gammie JS, Zenati M, Kormos RL, Hattler BG, Wei LM, Pellegrini RV y cols. Abciximab and excessive bleeding in patients undergoing emergency cardiac operations. Ann Thorac Surg 1998; 65: 465-9.

9. Bidstrup BP, Hunt BJ, Sheikh S, Parrat RN, Bidstrup JM, Sapsford RN. Amelioration of the bleeding tendency of preoperative aspirin after coronary aortocoronary bypass grafting. Ann Thorac Surg 2000; 69: 541-7.

10. Lemmer JH, Metzdorff MT, Krause AH, Martin MA, Okies JE, Hill JG. Emergency coronary artery bypass graft surgery in abciximab-treated patients. Ann Thorac Surg 2000; 66: 90-5.

11. Hekmat K, Clemens RM, Mehlhorn U, Geissler HJ, Kuhn RF, de Vivie ER. Emergency coronary artery surgery after failed PTCA: myocardial protection with continuous coronary perfusion of beta-blocker-enriched blood. Thorac Cardiovasc Surg 1998; 46: 333-8.

12. Carey JA, Davies SW, Balcon R, Layton C, Magee P, Rothman MT y cols. Emergency surgical revascularization for coronary angioplasty complications. Br Heart J 1994; 72: 428-35.